Fenofibrate's safety in these patients is an issue because it may elevate plasma creatinine. Furthermore, guidelines regarding fenofibrate dosing in renal impairment vary internationally.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback